Published in Cancer Weekly, July 13th, 1998
Genetronics is utilizing the long-established research technology called electroporation to more efficiently and effectively deliver life-saving drugs or beneficial genes directly into the human cell, Lois Crandell, Genetronics, told participants of the Cruttenden Roth Healthcare Conference in New York.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.